GO:1990432 siRNA 3'-end processing: Small RNA Maturation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990432 (siRNA 3'-end processing) is the biological process that forms the mature 3' end of small interfering RNA (siRNA) molecules, a required step for loading into Argonaute (Ago) and for RNA interference (RNAi).
• The process is mechanistically linked to broader 3'-end processing and stability pathways, including those that act on long noncoding RNA such as NEAT1 and on coding transcripts.
• Dicer-independent small RNA pathways, including tRNA-derived fragments (tRFs) that guide Ago, show that 3'-end maturation is not restricted to canonical Dicer-dependent siRNA biogenesis.
• Regulators of 3'-end processing can be inferred from multi-omics data, and their dysregulation is observed in cancer such as glioblastoma.
• Small RNA 3'-end processing intersects with piRNA biology and cardiovascular disease, indicating relevance beyond classical RNAi.
• Plant and animal studies show that processing of coding and noncoding RNAs is central to development and environmental responses, making siRNA 3'-end processing a conserved regulatory node.
Description
Small interfering RNAs (siRNAs) are short regulatory RNAs that guide Argonaute proteins to complementary transcripts and silence gene expression. For an siRNA to become functional, its 3' end must be correctly formed; GO:1990432, siRNA 3'-end processing, is the biological process that generates this mature 3' terminus. This step is essential because Ago loading and target recognition depend on the chemical and structural identity of the small RNA ends. Although the term is defined narrowly, the enzymes and cofactors that perform 3'-end processing also act on other RNA classes, linking siRNA maturation to long noncoding RNA stability and to polyadenylation-related pathways. Researchers study siRNA 3'-end processing because it sits at the intersection of RNAi, small RNA quality control, and gene regulation. Dicer-independent routes, such as tRNA-derived fragments that guide Ago, demonstrate that 3'-end maturation can occur through alternative mechanisms. Multi-omics analyses have begun to infer regulators of 3'-end processing in disease contexts, including glioblastoma, where processing changes may alter the small RNA repertoire. Related small RNA pathways, including piRNAs, are implicated in cardiovascular and other diseases, reinforcing the broader biomedical importance of 3'-end processing. Because the process is conserved and mechanistically coupled to RNA stability, it is also relevant to development and environmental responses in plants and other organisms. This article summarizes the QuickGO definition, the molecular and cellular context, the genes and regulators involved, disease links, and the experimental and CRISPR-based methods used to study GO:1990432.
siRNA 3'-end processing At A Glance
| GO ID | GO:1990432 |
|---|---|
| GO term | siRNA 3'-end processing |
| Ontology | biological_process |
| Synonym | siRNA 3' end processing; small interfering RNA 3'-end processing |
| Definition | The process of forming the mature 3' end of a siRNA molecule. |
| Major function | Maturation of siRNA 3' termini for Argonaute loading and RNA interference |
| Related processes | Dicer-independent small RNA biogenesis, tRNA-derived fragment (tRF) guided Ago regulation |
| Disease relevance | Processing regulators are implicated in cancer such as glioblastoma and in cardiovascular disease through related small RNA pathways |
| Conservation | Processing of coding and noncoding RNAs is conserved and important in plant development and environmental responses |
What Is GO:1990432?
GO:1990432, siRNA 3'-end processing, is defined by QuickGO as the process of forming the mature 3' end of a siRNA molecule. In other words, it covers the enzymatic and quality-control steps that convert a precursor small RNA into an siRNA with a correct, functional 3' terminus. This maturation is required for downstream Argonaute loading and RNAi activity. The term is a biological process and is closely related to other 3'-end processing events that act on noncoding and coding RNAs.
Why Is siRNA 3'-end processing Important in Cell Biology?
siRNA 3'-end processing is important because it determines whether a small RNA can be loaded into Argonaute and direct silencing. Without correct 3'-end formation, siRNA function is compromised, affecting RNAi-based regulation of gene expression. The same processing machinery and principles apply to other noncoding RNAs, so understanding GO:1990432 informs long noncoding RNA stability and nuclear organization, including NEAT1 and paraspeckle formation. In disease, altered 3'-end processing can reshape the small RNA landscape; multi-omics studies have inferred regulators of mRNA 3' end processing in glioblastoma, and related small RNA pathways such as piRNAs are linked to cardiovascular and other diseases. Finally, because RNA processing is central to development and environmental responses, siRNA 3'-end processing is relevant to both basic and applied biology.
• Required for Argonaute loading and RNA interference activity.
• Links canonical RNAi to Dicer-independent small RNA pathways such as tRF-guided Ago regulation.
• Shares machinery and logic with 3'-end processing of long noncoding RNAs such as NEAT1.
• Connects to polyadenylation and 3'-end processing pathways with broad health and disease implications.
• Regulators of 3'-end processing can be inferred from multi-omics data in cancer such as glioblastoma.
• Related small RNA pathways, including piRNAs, are implicated in cardiovascular disease.
• Processing of coding and noncoding RNAs is central to plant development and environmental responses.
• Provides a mechanistic entry point for understanding small RNA quality control and stability.
• Offers candidate targets for experimental perturbation using CRISPR and RNA-based methods.
• Relevant to biomarker and therapeutic development in diseases driven by small RNA dysregulation.
What Happens During siRNA 3'-end processing?
Generation of the siRNA precursor
In simple terms: First, a longer RNA is cut down to a short double-stranded RNA that will become an siRNA.
siRNA 3'-end processing begins with a precursor small RNA. In canonical RNAi, a longer double-stranded RNA is cleaved into short duplexes, after which the 3' end must be trimmed or otherwise matured. Dicer-independent pathways also produce small RNAs that require 3'-end maturation before they can guide Ago. The existence of tRF-guided Ago regulation shows that precursor generation is not limited to the canonical Dicer route.
3' terminal trimming and maturation
In simple terms: The 3' end of the short RNA is trimmed to its final, correct length and chemistry.
The defining step of GO:1990432 is formation of the mature 3' end. This involves removing extra 3' nucleotides and establishing the terminal structure required for Argonaute binding. Because Ago loading depends on the small RNA ends, defects in 3'-end maturation reduce silencing efficiency. The same principle applies to other noncoding RNAs whose 3' ends are processed for stability and function, such as NEAT1.
Quality control and stability
In simple terms: The cell checks whether the 3' end is correct and stabilizes or degrades the RNA accordingly.
3'-end processing is coupled to RNA stability. For long noncoding RNAs such as NEAT1, 3'-end processing and stability are linked to paraspeckle formation. Polyadenylation and 3'-end processing pathways also influence transcript fate in health and disease. These observations support a model in which siRNA 3'-end processing is part of a broader quality-control network that determines whether a small RNA survives and functions.
Loading into Argonaute
In simple terms: Once the 3' end is mature, the siRNA is loaded into an Argonaute protein to silence targets.
Mature 3' ends are required for efficient Argonaute loading. tRFs guide Ago to regulate gene expression post-transcriptionally in a Dicer-independent manner, demonstrating that 3'-end-matured small RNAs can enter Ago complexes through multiple routes. This step connects GO:1990432 directly to downstream gene silencing and to the broader small RNA regulatory network.
Integration with other RNA processing pathways
In simple terms: siRNA 3'-end processing does not happen in isolation; it overlaps with other RNA processing events.
Processing of coding and noncoding RNAs is coordinated in development and environmental responses. Regulators of 3'-end processing can be inferred from multi-omics data, as shown for mRNA 3' end processing in glioblastoma. Related small RNA pathways, including piRNAs, are also subject to processing and regulatory control in disease. Thus, siRNA 3'-end processing should be viewed as one node in an integrated RNA processing network.
Key Genes Involved in GO:1990432 siRNA 3'-end processing
The following genes and proteins are experimentally or conceptually linked to siRNA 3'-end processing and related small RNA maturation pathways, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AGO | Argonaute effector protein that binds mature small RNAs | Central to siRNA function; loading depends on 3'-end maturation |
| DICER | Canonical small RNA processing enzyme | Canonical siRNA biogenesis; Dicer-independent routes also exist |
| ARS2 | Regulates 3'-end processing and stability of NEAT1 lncRNA | Links 3'-end processing to paraspeckle formation |
| NEAT1 | Long noncoding RNA whose 3'-end processing drives paraspeckles | Model for 3'-end processing and stability |
| CPSF | Cleavage and polyadenylation specificity factor complex | Core 3'-end processing machinery with disease implications |
| CSTF | Cleavage stimulation factor complex | 3'-end processing of coding and noncoding transcripts |
| PAP | Poly(A) polymerase | Polyadenylation and 3'-end maturation |
| PIWI | piRNA-binding Argonaute family protein | Related small RNA pathway in disease |
| PIWIL | PIWI-like proteins | piRNA biology and cardiovascular disease |
| tRF-generating enzymes | Produce tRNA-derived fragments that guide Ago | Dicer-independent small RNA maturation |
| Processing regulators (multi-omics inferred) | Candidate regulators of 3' end processing | Inferred in glioblastoma multi-omics studies |
| Plant RNA processing factors | Processing of coding and noncoding RNAs | Conserved roles in development and stress responses |
| Exosome-associated factors | RNA trimming and degradation | Quality control of 3' ends |
| RNA helicases | RNA structure remodeling during processing | Facilitate 3'-end maturation |
| Small RNA methyltransferases | Terminal modification of small RNAs | Stabilize mature 3' ends |
| Argonaute-associated chaperones | Assist small RNA loading | Support siRNA function after 3'-end processing |
| Nuclear paraspeckle proteins | Assemble on NEAT1 after 3'-end processing | Readout of 3'-end processing status |
| Polyadenylation regulators | Modulate 3'-end processing efficiency | Disease-relevant processing control |
How Is siRNA 3'-end processing Regulated?
Regulation of siRNA 3'-end processing is coupled to broader RNA processing control. Multi-omics approaches have been used to infer regulators of mRNA 3' end processing in glioblastoma, showing that processing is subject to cell-state and disease-specific regulation. 3'-End processing and stability of the long noncoding RNA NEAT1 are regulated by factors such as ARS2, which in turn affects nuclear paraspeckle formation. Polyadenylation and 3'-end processing pathways are also regulated in health and disease, providing a framework for understanding how siRNA 3'-end maturation may be controlled. Related small RNA pathways, including piRNAs, are regulated in cardiovascular and other disease contexts. In plants, processing of coding and noncoding RNAs is regulated during development and environmental responses, indicating conserved regulatory principles.
siRNA 3'-end processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AGO | RNAi dysfunction and gene regulation | AGO knockout and point-mutation cell lines |
| ARS2 | Paraspeckle formation and NEAT1 processing | ARS2 knockout with NEAT1 3'-end processing assays |
| NEAT1 | Nuclear paraspeckle biology | NEAT1 knockout and knock-in reporter lines |
| CPSF/CSTF | 3'-end processing in cancer and disease | Knockout and overexpression models in glioblastoma cells |
| PIWI/PIWIL | Cardiovascular disease | PIWI-family knockout and overexpression models |
Cancer and glioblastoma
Dysregulation of 3'-end processing can alter the small RNA and mRNA landscape in cancer. Multi-omics data have been used to infer regulators of mRNA 3' end processing in glioblastoma, highlighting processing factors as candidate disease modulators. Because siRNA 3'-end processing determines small RNA function, changes in this step could affect RNAi-based gene regulation in tumors.
Cardiovascular disease and piRNA biology
Related small RNA pathways, particularly piRNAs, have regulatory roles in cardiovascular disease. Although piRNAs are distinct from siRNAs, they share principles of small RNA 3'-end maturation and Argonaute loading, making siRNA 3'-end processing relevant to cardiovascular small RNA biology.
Nuclear organization and paraspeckle-related pathology
3'-End processing and stability of NEAT1 are required for nuclear paraspeckle formation, and ARS2 regulates this process. Perturbations in NEAT1 processing can therefore affect nuclear organization, which has been linked to stress responses and disease-relevant cellular states.
Developmental and environmental stress responses
Processing of coding and noncoding RNAs is important in plant development and environmental responses. This conservation suggests that defects in 3'-end processing can affect organismal development and stress adaptation, providing a broader disease-relevant context for GO:1990432.
From siRNA 3'-end processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for siRNA 3'-end processing? | CRISPR knockout cell line followed by small RNA sequencing |
| Does a specific residue control processing activity? | CRISPR point-mutation knock-in of the catalytic or binding residue |
| How does a processing factor affect Argonaute loading? | Tagged knock-in of AGO with small RNA profiling |
| Does overexpression of a processing factor change the small RNA repertoire? | Doxycycline-inducible overexpression cell line |
| Which regulators control 3'-end processing in disease? | CRISPR library screening combined with multi-omics |
| How does 3'-end processing affect paraspeckle formation? | NEAT1 reporter knock-in with ARS2 perturbation |
How to Study the siRNA 3'-end processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Small RNA sequencing | Mature siRNA 3' ends and length distribution | Assessing 3'-end processing defects |
| Multi-omics integration | Candidate regulators of 3' end processing | Inferring processing control in cancer |
| Argonaute immunoprecipitation | Small RNAs loaded into Ago | Linking 3'-end maturation to RNAi |
| Reporter gene silencing assay | Functional RNAi activity | Testing processing mutants |
| Paraspeckle imaging | NEAT1 processing and stability readout | Studying ARS2 and NEAT1 function |
| Polyadenylation assays | 3'-end processing of coding transcripts | Comparing shared machinery |
| piRNA profiling | Related small RNA pathway activity | Cardiovascular disease studies |
| Plant RNA processing assays | Coding and noncoding RNA processing | Developmental and stress studies |
Small RNA sequencing and 3'-end mapping
Small RNA sequencing can quantify mature siRNA species and map their 3' ends. Comparing wild-type and perturbed cells reveals whether a candidate gene affects 3'-end formation. This approach is central to studying GO:1990432 because the readout is the mature 3' terminus.
Multi-omics inference of processing regulators
Multi-omics data can be used to infer regulators of 3' end processing, as demonstrated in glioblastoma. Integrating transcriptomic, proteomic, and small RNA data helps identify candidate factors that control siRNA 3'-end maturation.
RNA imaging and paraspeckle assays
Because 3'-end processing and stability of NEAT1 drive paraspeckle formation, imaging of nuclear paraspeckles provides a functional readout of processing status. ARS2 perturbation alters paraspeckle formation, linking processing to nuclear organization.
Argonaute loading and functional RNAi assays
Argonaute immunoprecipitation followed by small RNA sequencing measures loading of mature siRNAs. Functional reporter assays then test whether 3'-end processing defects reduce silencing. These methods connect molecular processing to RNAi activity.
How CRISPR Can Be Used to Study GO:1990432 siRNA 3'-end processing
Knockout
CRISPR knockout of candidate processing genes, such as AGO, ARS2, or polyadenylation factors, can test whether they are required for siRNA 3'-end processing. Knockout cells are then analyzed by small RNA sequencing and Argonaute loading assays. This approach directly addresses causality for GO:1990432.
Point Mutation
Point-mutation knock-in can dissect catalytic residues or binding interfaces in processing enzymes. For example, mutating a residue in a 3'-end processing factor can separate its role in siRNA maturation from other functions. Such models provide mechanistic resolution beyond simple knockout.
Knock-in
Tagged knock-in of AGO or processing factors enables immunoprecipitation and localization studies. Tagged AGO knock-in allows profiling of loaded small RNAs and their 3' ends. Knock-in reporters for NEAT1 can monitor 3'-end processing and paraspeckle formation in live cells.
Overexpression
Overexpression of processing factors or small RNA pathway components can reveal gain-of-function effects on the small RNA repertoire. Inducible overexpression models are useful for testing whether increased processing activity changes siRNA maturation or disease-relevant phenotypes. Overexpression can also complement loss-of-function studies.
How EDITGENE Supports siRNA 3'-end processing Research
Researchers studying siRNA 3'-end processing-related genes often need to determine whether a candidate gene is causally involved in small RNA maturation, Argonaute loading, or disease-relevant processing changes. EDITGENE provides CRISPR-based cell model services that enable loss-of-function, point-mutation, knock-in, and overexpression studies tailored to GO:1990432 and related RNA processing pathways.
Contact EDITGENE today to design your custom CRISPR model for siRNA 3'-end processing research.
Frequently Asked Questions About siRNA 3'-end processing
What is GO:1990432?
GO:1990432 is the Gene Ontology biological process term for siRNA 3'-end processing, defined as the process of forming the mature 3' end of a siRNA molecule.
What is siRNA 3'-end processing?
It is the maturation step that generates the correct 3' terminus of an siRNA, enabling Argonaute loading and RNA interference.
What genes are involved in siRNA 3'-end processing?
Genes and proteins linked to this process include AGO, DICER, ARS2, NEAT1, and polyadenylation factors such as CPSF and CSTF, based on related 3'-end processing literature.
Why is siRNA 3'-end processing important?
Because Argonaute loading and RNAi activity depend on a mature 3' end; defects reduce small RNA function and can alter gene regulation.
Is siRNA 3'-end processing related to Dicer?
Canonical siRNA biogenesis involves Dicer, but Dicer-independent pathways such as tRF-guided Ago regulation also require 3'-end maturation.
How is siRNA 3'-end processing studied?
Common methods include small RNA sequencing, Argonaute immunoprecipitation, reporter silencing assays, and multi-omics inference of processing regulators.
What diseases are linked to 3'-end processing?
Regulators of 3' end processing have been inferred in glioblastoma, and related small RNA pathways such as piRNAs are implicated in cardiovascular disease.
Can CRISPR be used to study siRNA 3'-end processing?
Yes. CRISPR knockout, point mutation, knock-in, and overexpression models can test whether candidate genes are required for 3'-end maturation and RNAi.
What is the connection between NEAT1 and 3'-end processing?
3'-End processing and stability of NEAT1 are required for nuclear paraspeckle formation, and ARS2 regulates this process.
Where can I find authoritative information on GO:1990432?
QuickGO provides the official definition and ontology annotation for GO:1990432, and PubMed literature provides experimental context.
Conclusion
GO:1990432, siRNA 3'-end processing, is a focused but mechanistically central biological process that generates the mature 3' end of siRNAs required for Argonaute loading and RNA interference. It is coupled to broader 3'-end processing and stability pathways, including those acting on NEAT1 and coding transcripts, and its regulators can be inferred from multi-omics data in disease such as glioblastoma. Related small RNA pathways, including piRNAs, extend its biomedical relevance to cardiovascular and other diseases. Studying siRNA 3'-end processing benefits from integrated approaches: small RNA sequencing, Argonaute profiling, imaging of paraspeckles, and CRISPR-based perturbation of candidate genes. EDITGENE supports these efforts with knockout, point-mutation, knock-in, overexpression, and library screening services tailored to RNA processing research.
References
- 1. Kuscu C et al.. 2018. tRNA fragments (tRFs) guide Ago to regulate gene expression post-transcriptionally in a Dicer-independent manner.. RNA 24(8):1093-1105 PMID: 29844106
- 2. Mironov A et al.. 2024. Leveraging multi-omics data to infer regulators of mRNA 3' end processing in glioblastoma.. Front Mol Biosci 11:1363933 PMID: 39188787
- 3. Machitani M et al.. 2020. ARS2 Regulates Nuclear Paraspeckle Formation through 3'-End Processing and Stability of NEAT1 Long Noncoding RNA.. Mol Cell Biol 40(4) PMID: 31818879
- 4. Naganuma T et al.. 2012. Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles.. EMBO J 31(20):4020-34 PMID: 22960638
- 5. Shivam P et al.. 2025. Regulatory roles of PIWI-interacting RNAs in cardiovascular disease.. Am J Physiol Heart Circ Physiol 328(4):H991-H1004 PMID: 40048207
- 6. Curinha A et al.. 2014. Implications of polyadenylation in health and disease.. Nucleus 5(6):508-19 PMID: 25484187
- 7. Wang K et al.. 2021. Emerging functions of piwi-interacting RNAs in diseases.. J Cell Mol Med 25(11):4893-4901 PMID: 33942984
- 8. Si F et al.. 2020. Processing of coding and non-coding RNAs in plant development and environmental responses.. Essays Biochem 64(6):931-945 PMID: 33236759
